Funding Opportunities

• Medical Simulators for Practicing Patient Care Providers Skill Acquisition, Outcomes Assessment and Technology Development (R01 Clinical Trial Not Allowed)
  (PA-19-065)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first application due date for this FOA is February 5, 2019.
• Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)
  (PA-19-066)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. First standard application due date for this FOA is February 16, 2019.
• Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed)
  (PA-19-067)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. First standard application due date for this FOA is February 5, 2019
• Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed)
  (PA-19-068)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 16, 2019.
• Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)
  (PAR-19-069)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  National Heart, Lung, and Blood Institute
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard ?a?p?p?l?i?c?a?t?i?o?n? ?d?u?e? date for this FOA is February 16, 2019.
• Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
  (PAR-19-070)
  National Institute on Aging
  National Institute of Neurological Disorders and Stroke
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): March 11, 2019; July 9, 2019; November 12, 2019; March 11, 2020; July 9, 2020; November 12, 2020; March 11, 2021; July 9, 2021; and November 12, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)
  (PAR-19-071)
  National Institute on Aging
  Application Receipt Date(s): March 11, 2019; July 9, 2019; November 12, 2019; March 11, 2020; July 9, 2020; November 12, 2020; March 11, 2021; July 9, 2021; and November 12, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Optional)
  (RFA-AA-19-005)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): February 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Single-Cell Multi-Omics of HIV Persistence (R01 Clinical Trial Not Allowed)
  (RFA-AI-18-053)
  National Institute of Allergy and Infectious Diseases
  National Institute of Mental Health
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Dates listed below
• Implementation Science for Cancer Control: Developing Centers (P50 Clinical Trial Optional)
  (RFA-CA-19-005)
  National Cancer Institute
  Application Receipt Date(s): February 11, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Implementation Science for Cancer Control: Advanced Centers (P50 Clinical Trial Optional)
  (RFA-CA-19-006)
  National Cancer Institute
  Application Receipt Date(s): February 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed)
  (RFA-DE-19-008)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): January 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
• Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed)
  (RFA-DE-19-009)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): January 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.